Lupu Cristina, Patel Maulin M, Lupu Florea
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Int J Mol Sci. 2021 Apr 24;22(9):4451. doi: 10.3390/ijms22094451.
The novel protein ADTRP, identified and described by us in 2011, is androgen-inducible and regulates the expression and activity of Tissue Factor Pathway Inhibitor, the major inhibitor of the Tissue Factor-dependent pathway of coagulation on endothelial cells. Single-nucleotide polymorphisms in ADTRP associate with coronary artery disease and myocardial infarction, and deep vein thrombosis/venous thromboembolism. Some athero-protective effects of androgen could exert through up-regulation of expression. We discovered a critical role of ADTRP in vascular development and vessel integrity and function, manifested through Wnt signaling-dependent regulation of matrix metalloproteinase-9. ADTRP also hydrolyses fatty acid esters of hydroxy-fatty acids, which have anti-diabetic and anti-inflammatory effects and can control metabolic disorders. Here we summarize and analyze the knowledge on ADTRP and try to decipher its functions in health and disease.
我们于2011年鉴定并描述的新型蛋白质ADTRP是雄激素诱导型的,可调节组织因子途径抑制剂的表达和活性,组织因子途径抑制剂是内皮细胞上组织因子依赖性凝血途径的主要抑制剂。ADTRP中的单核苷酸多态性与冠状动脉疾病、心肌梗死以及深静脉血栓形成/静脉血栓栓塞有关。雄激素的一些抗动脉粥样硬化作用可能通过上调其表达来发挥。我们发现ADTRP在血管发育、血管完整性和功能中起关键作用,这通过Wnt信号依赖的基质金属蛋白酶-9调节得以体现。ADTRP还能水解具有抗糖尿病和抗炎作用且可控制代谢紊乱的羟基脂肪酸的脂肪酸酯。在此,我们总结并分析关于ADTRP的知识,并试图解读其在健康和疾病中的功能。